News tagged with adjuvant
New discovery may lead the way to improved whooping cough vaccine
Scientists at Trinity College Dublin have made novel discoveries concerning the current vaccine against whooping cough that may lead to the development of an improved future vaccine. The findings could help reduce the incidence ...
Diseases, Conditions, Syndromes
May 13, 2013 |
not rated yet |
0
Vaccine adjuvant uses host DNA to boost pathogen recognition
Aluminum salts, or alum, have been injected into billions of people as an adjuvant to make vaccines more effective. No one knows, however, how they boost the immune response. In the March 19, 2013, issue of the Proceedings of ...
Medical research
Apr 05, 2013 |
5 / 5 (2) |
0
|
Epigenetic changes play a key role in development of chemo resistance in BCa
At the 28th Annual EAU Congress currently ongoing in Milan until Tuesday, W. Tan and colleagues presented their study on neoadjuvant cisplatin-based chemotherapy which showed that epigenetic changes are potential key drivers ...
Cancer
Mar 18, 2013 |
not rated yet |
0
Prospective study finds many children with retinoblastoma can safely forego adjuvant chemotherapy
New results from a prospective clinical trial conducted in France show that children with low-risk retinoblastoma do not need postoperative (adjuvant) chemotherapy to prevent disease recurrence or metastasis; the results ...
Cancer
Mar 04, 2013 |
not rated yet |
0
Cancer vaccines self-sabotage, channel immune attack to injection site
Cancer vaccines that attempt to stimulate an immune system assault fail because the killer T cells aimed at tumors instead find the vaccination site a more inviting target, scientists at The University of Texas MD Anderson ...
Medical research
Mar 03, 2013 |
4.8 / 5 (5) |
1
|
Major step toward an Alzheimer's vaccine
A team of researchers from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK) has discovered a way to stimulate the brain's natural defense mechanisms in people with Alzheimer's disease. This ...
Alzheimer's disease & dementia
Jan 15, 2013 |
5 / 5 (4) |
0
Researcher shows diabetes, blood pressure link to colon cancer recurrence, survival
By all accounts, a combination of colon cancer, diabetes and high blood pressure can be a recipe for medical disaster. Now, a new study led by a surgical oncologist and researcher at Temple University School of Medicine and ...
Cancer
Dec 20, 2012 |
not rated yet |
0
Bevacizumab doesn't prolong survival in stage II-III colon CA
(HealthDay)—For patients with stage 2 to 3 colon cancer, the addition of bevacizumab to modified fluorouracil, leucovorin, and oxaliplatin (FOLFOX6) does not prolong disease-free or overall survival, according ...
Cancer
Dec 12, 2012 |
not rated yet |
0
Chemo may extend survival after breast cancer's return
(HealthDay)—In women with breast cancer that has recurred but remains confined to in or near the breast, post-surgical chemotherapy appears to boost survival, new research shows.
Cancer
Dec 06, 2012 |
not rated yet |
0
Using unique combination of diet and radiation therapy, researchers successfully destroy brain tumor cells
A team of brain cancer researchers at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has effectively treated brain tumor cells using a unique combination of diet and radiation therapy. The study, ...
Cancer
Dec 04, 2012 |
5 / 5 (1) |
0
|
Heart failure in older breast cancer patients linked to medication
Heart failure is a relatively common complication in older women with breast cancer, but the risk is even higher in those patients treated with adjuvant trastuzumab (Herceptin), Yale School of Medicine researchers report ...
Cardiology
Nov 14, 2012 |
not rated yet |
0
|
IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: ...
Medications
Aug 16, 2012 |
not rated yet |
0
Flu vaccine research: overcoming 'original sin'
(Medical Xpress) -- Scientists studying flu vaccines have identified ways to overcome an obstacle called "original antigenic sin," which can impair immune responses to new flu strains.
Immunology
Aug 13, 2012 |
3.7 / 5 (3) |
1
|
Study links age, insurance, but not race, to chemo rates
(HealthDay) -- For women with breast cancer, disease characteristics correlate significantly with chemotherapy receipt, with no indication of racial barriers to treatment, according to a study published online ...
Cancer
Aug 10, 2012 |
not rated yet |
0
Keeping the flu away: Synthetic protein EP67 helps kick-start the immune system
San Diego State University researchers at the Donald P. Shiley BioScience Center may have found the secret to helping the immune system fight off the flu before it gets you sick.
Immunology
Jul 06, 2012 |
4 / 5 (4) |
0
|
Adjuvant
An adjuvant (from Latin, adiuvare: to aid) is a pharmacological or immunological agent that modifies the effect of other agents, such as a drug or vaccine, while having few if any direct effects when given by itself. They are often included in vaccines to enhance the recipient's immune response to a supplied antigen, while keeping the injected foreign material to a minimum.
For more information about Adjuvant, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
